与药物相关的尿道炎:基于食品和药物管理局不良事件报告系统数据库的现实研究
Bing Yan1, Shi-Nan Wu1, Xiao-Dong Chen1
1Xiamen University affiliated Xiamen Eye Center; Fujian Provincial Key Laboratory of Ophthalmology and Visual Science; Fujian Engineering and Research Center of Eye Regenerative Medicine; Eye Institute of Xiamen University; School of Medicine, Xiamen University, Xiamen, Fujian, China.
概括
这项研究确定了39种与药物相关的脑膜炎 (DRU) 相关的药物,其中法里西马布,佩格塞塔科普兰和利法布丁具有最高的风险. 早期识别DRU风险对于预防至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 眼科医生 眼科 眼科
- 药品安全 药品安全
背景情况:
- 与药物相关的脑膜炎 (DRU) 是一种显著的药物不良事件.
- 了解DRU的流行病学特征和风险因素对于患者安全至关重要.
- 现实世界的数据分析为药物安全概况提供了有价值的见解.
研究的目的:
- 通过使用真实世界的数据来评估与药物相关的脑膜炎 (DRU) 的药物风险.
- 识别与DRU相关的特定药物并量化其风险.
- 追踪DRU的流行病学趋势和特征.
主要方法:
- 从FDA不良事件报告系统 (FAERS) 数据库 (2004-2024) 中分析药物不良事件数据.
- 不成比例分析和贝叶斯信心传播神经网络 (BCPNN) 算法的应用.
- 对DRU的分类,风险评估和药物诱导发病时间的比较.
主要成果:
- 在报告的269种药物中,有39种药物被确定为DRU的积极信号.
- 高风险药物包括法里西马布,佩格塞塔科普兰和里法布丁.
- 抗生素显示出最短的发病时间 (20.55天);女性和老年人主要受到影响. 在过去的20年里,DRU的发病率呈现出不断增加的趋势.
结论:
- 预防DRU比治疗更有效.
- 识别药物风险和开始时间有助于药物评估和DRU预防.
- 现实世界的数据分析对于积极的药物安全监测至关重要.
相关概念视频
01:19Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
01:29Therapeutic Drug Monitoring: Affecting Factors
283
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
283
01:16Therapeutic Drug Monitoring: Overview and Classification
434
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
434
01:25Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
01:30Drug Toxicity: Allergic Reactions
59
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
59
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
190
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
190